Growth Metrics

Allurion Technologies (ALURW) Preferred Shares (2022 - 2023)

Allurion Technologies posted quarterly Preferred Shares of $2.8 million for Q4 2023, down 95.1% year-on-year from $58.0 million in Q4 2022, and up 84.31% on a QoQ basis from $1.5 million in Q3 2023.

Allurion Technologies (ALURW) has 2 years of Preferred Shares data on file, last reported at $2.8 million in Q4 2023.

  • For the quarter ending Q4 2023, Preferred Shares fell 95.1% year-over-year to $2.8 million; the trailing twelve-month figure through Dec 2023 stood at $2.8 million (down 95.1% YoY), and the FY2023 full-year result was $2.8 million, down 95.1% from the prior year.
  • Preferred Shares for Q4 2023 stood at $2.8 million, up from $1.5 million in the prior quarter.
  • Across five years, Preferred Shares topped out at $58.0 million in Q2 2023 and bottomed at $1.5 million in Q3 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Shares (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Allurion Technologies - - 1.23 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2023 5.25 Mn
Sep 30, 2023 2.84 Mn
Jun 30, 2023 58.03 Mn
Dec 31, 2022 58.00 Mn